75 results
Page 4 of 4
F-1/A
3ak02
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1
m5jtfbco2 w1xg347
31 Jan 20
Registration statement (foreign)
12:00am
424B5
zs82ztfg6
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
pe7optrlq3xr4
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-99.1
btf2mfpah19ni5
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm
424B5
zdc6910 87
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
2yi1xewkwzibxf
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-99.1
1gd4r39rhps
24 Oct 18
Report of Foreign Private Issuer
6:45am
424B2
cyqv59jf255g6 qmys
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
qv40lz c517pi
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm
F-3
ochh6x 0fcv
20 Jun 18
Shelf registration (foreign)
2:38pm
20-F
y2fp5fmbk8
1 May 17
Annual report (foreign)
12:00am
20-F
EX-4.3
xi9 tnt0ysxn214yysnx
1 May 17
Annual report (foreign)
12:00am